China Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9, Find details about China Semaglutide, Liraglutide from Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9
Product Name | CAS No. | Molecular Formula |
Orlist | 96829-58-2 | C29H53NO5 |
Cetilistat | 282526-98-1 | C25H39NO3 |
Topiramate | 97240-79-4 | C12H21NO8S |
L-Carnitine | 541-15-1 | C7H15NO3 |
Lorca hydrochloride hemihydrate | 856681-05-5 | C22H32Cl4N2O |
Lorca Hydrochloride | 846589-98-8 | C11H15Cl2N |
Lorca | 616202-92-7 | C11H14ClN |
Rimonabant | 168273-06-1 | C22H21Cl3N4O |
Metformin | 657-24-9 | C4H11N5 |
Liraglutide | 204656-20-2 | C172H265N43O51 |
Semaglutide | 782487-28-9 | C20H35NO2 |
Synephrine hydrochloride | 5985-28-4 | C9H14ClNO2 |
Bupropion | 34911-55-2 | C13H18ClNO |
Hordenine hydrochloride | 6027-23-2 | C10H16ClNO |
(-)-Huperzine A | 102518-79-6 | C15H18N2O |
Alpha-Lipoic Acid | 1077-28-7 | C8H14O2S2 |
6-Paradol | 27113-22-0 | C17H26O3 |
9-Fluorenol(Hydrafinil) | 1689-64-1 | C13H10O |
Appearance | White powder. |
Purity | 99%min |
Single Impurity (HPLC) | 1.0%max |
Amino Acid Composition | ±10% of theoretical |
Peptide Content (N%) | ≥80.0% |
Water Content(Karl Fischer) | ≤6.0% |
Acetate Content (HPIC) | ≤15.0% |
MS(ESI) | Consistent |
Mass Balance | 95.0~105.0% |
Specific Rotation (20/D) | -65.0~-75.0°(c=0.5 1%HAc) |
Solubility | H 2 O:40 mg / mL |
Storage condition | -20ºC |
Shelf life | 2 years |